Not surprisingly we are in a post earnings lull. While there are still earnings being posted, the bulk of the major ones have been reported. We are also seeing the.
The sector continues to do well this week on not necessarily all positive news. My refrain will continue to be that we are range bound until proven otherwise and so.
We start off a little weak this morning, which is not completely unexpected given that we are at the top end of the recent range. Obviously it would be nice.
There might be reason for optimism in the sector. The XBI seems to be breaking above its recent range and the $80 level might have been support for this new.
Another day and another weak earning for biotech. This was fairly predictable and the real question is how far these earnings (and the upcoming slew of secondaries now that the.
An interesting start to large cap earnings. The sector was weak yesterday and this could be the long awaited pullback (or another head fake). Ideally, the pullback bottoms out in.
Another day and another lackluster pharma earnings. In some sense, it is good to see this have limited impact on the sector but on the other hand this is certainly.
A short note today as there is not much going on. We have earnings starting next week so the pace of news should pick up but at this point, I.
Real quick post on CELG. I sold my position for $86.28. I wanted to lock in profits and while there is still a nice gap between current price and deal.
We are clearly not out of the woods for a correction but we should also remember that corrections can occur through price or time. In other words, most think of.
The sector move seems to be losing some steam. This is not unexpected nor bad as these overbought conditions need to be reset. The real key going forward is not.